This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
    • Chapter 1
    • Chapter 2
    • Chapter 3
    • Chapter 4
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Addressing Unmet Needs in Patients with Epilepsy: Perspectives on Comorbidities, Special Populations, and Initiating Early Treatment

Addressing Unmet Needs in Patients with Epilepsy: Perspectives on Comorbidities, Special Populations, and Initiating Early Treatment

Format

Webcast

Time to Complete

1.25 hours

Released

October 2, 2017

Expires

October 2, 2018
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 CreditsTM

Accredited Provider



Provided by Integrity Continuing Education, Inc.

Commercial Supporter

Supported by an educational grant from UCB

Program Description

Patients suffering from epilepsy have both short- (eg, seizure control) and long-term (eg, uncontrolled comorbidities and low quality of life [QOL]) unmet medical needs. In addition to regular disease activity monitoring, appropriate management of comorbid conditions, addressing the individual needs of special populations, including female and elderly patients, and QOL issues are important components of care for patients with epilepsy. The advancement of adjunctive therapies also requires discussion since newer therapies with different mechanisms of action may be more effective, and therefore could eliminate the need for multiple anti-epilepsy drug therapy in patients with epilepsy. Through education, practitioners may be able to achieve better patient outcomes in these areas of care.

Intended Audience

This educational initiative has been designed for neurologists and internal medicine physicians involved in the management of patients with epilepsy.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Utilize strategies to identify important comorbidities of epilepsy and ameliorate their impact on patient quality of life
  • Identify unmet medical needs of special populations, including female and elderly patients, with epilepsy
  • Describe the importance of optimizing treatment of focal seizures early in the epilepsy treatment trajectory

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Gregory K. Bergey, MD
Professor of Neurology
Director, Johns Hopkins Epilepsy Center
The Johns Hopkins University
Baltimore, MD

Dr. Bergey has no real or apparent conflicts of interest to report.

Robert Fisher, MD, PhD
Maslah Saul MD Professor of Neurology and Neurological Sciences
Stanford University
Palo Alto, CA

Dr. Fisher discloses the following:
Consulting Fees: Engage Therapeutics
Ownership Interest: Avails Medical, Cerebral Therapeutics, SmartWatch, Zeto

Accredited Provider Disclosure

Patima Tanapat, PhD, has no real or apparent conflicts of interest to disclose.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and UCB do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and UCB. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of October 2, 2017 through October 2, 2018, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 100%.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or information@integrityce.com.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue